GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guobang Pharma Ltd (SHSE:605507) » Definitions » EV-to-FCF

Guobang Pharma (SHSE:605507) EV-to-FCF : 104.67 (As of Jul. 23, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Guobang Pharma EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Guobang Pharma's Enterprise Value is ¥10,527 Mil. Guobang Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was ¥101 Mil. Therefore, Guobang Pharma's EV-to-FCF for today is 104.67.

The historical rank and industry rank for Guobang Pharma's EV-to-FCF or its related term are showing as below:

SHSE:605507' s EV-to-FCF Range Over the Past 10 Years
Min: -153.85   Med: -19.33   Max: 989.16
Current: 103.23

During the past 8 years, the highest EV-to-FCF of Guobang Pharma was 989.16. The lowest was -153.85. And the median was -19.33.

SHSE:605507's EV-to-FCF is ranked worse than
83.46% of 532 companies
in the Drug Manufacturers industry
Industry Median: 25.5 vs SHSE:605507: 103.23

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-07-23), Guobang Pharma's stock price is ¥21.07. Guobang Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥1.420. Therefore, Guobang Pharma's PE Ratio (TTM) for today is 14.84.


Guobang Pharma EV-to-FCF Historical Data

The historical data trend for Guobang Pharma's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guobang Pharma EV-to-FCF Chart

Guobang Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial - -22.62 59.13 -35.49 34.43

Guobang Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.40 -24.72 168.31 34.43 100.73

Competitive Comparison of Guobang Pharma's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Guobang Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guobang Pharma's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guobang Pharma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Guobang Pharma's EV-to-FCF falls into.


;
;

Guobang Pharma EV-to-FCF Calculation

Guobang Pharma's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=10527.032/100.569
=104.67

Guobang Pharma's current Enterprise Value is ¥10,527 Mil.
Guobang Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥101 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guobang Pharma  (SHSE:605507) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Guobang Pharma's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=21.07/1.420
=14.84

Guobang Pharma's share price for today is ¥21.07.
Guobang Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.420.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Guobang Pharma EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Guobang Pharma's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Guobang Pharma Business Description

Traded in Other Exchanges
N/A
Address
No. 60, Xingmei Avenue, Provincial High-tech Industrial Park, Zhejiang Province, Xinchang, CHN, 312500
Guobang Pharma Ltd is engaged in the research and development, production and sales of related products in the field of medicine and animal health products.

Guobang Pharma Headlines

No Headlines